|
| Status |
Public on Dec 27, 2012 |
| Title |
The ets transcription factor ELF5 suppresses the estrogen sensitive phenotype and contributes to antiestrogen resistance in luminal breast cancer. |
| Organism |
Homo sapiens |
| Experiment type |
Expression profiling by array
Genome binding/occupancy profiling by high throughput sequencing
|
| Summary |
This SuperSeries is composed of the SubSeries listed below.
|
| |
|
| Overall design |
Refer to individual Series
|
| |
|
| Citation(s) |
23300383 |
| Submission date |
Jul 05, 2011 |
| Last update date |
May 15, 2019 |
| Contact name |
Mark Cowley |
| E-mail(s) |
m.cowley@garvan.org.au
|
| Organization name |
Garvan Institute of Medical Research
|
| Department |
Genome Informatics & Clinical Genomics
|
| Lab |
Dinger lab
|
| Street address |
384 Victoria St.
|
| City |
Darlinghurst |
| State/province |
NSW |
| ZIP/Postal code |
2010 |
| Country |
Australia |
| |
|
| Platforms (2) |
| GPL6244 |
[HuGene-1_0-st] Affymetrix Human Gene 1.0 ST Array [transcript (gene) version] |
| GPL10999 |
Illumina Genome Analyzer IIx (Homo sapiens) |
|
| Samples (18)
|
|
| This SuperSeries is composed of the following SubSeries: |
| GSE30405 |
The ets transcription factor ELF5 suppresses the estrogen sensitive phenotype and contributes to antiestrogen resistance in luminal breast cancer. [human] |
| GSE31216 |
The ets transcription factor ELF5 suppresses the estrogen sensitive phenotype and contributes to antiestrogen resistance in luminal breast cancer. [human ChIP-Seq] |
|
| Relations |
| BioProject |
PRJNA143669 |
Less...
More...